News
The PhD Day returns this year stronger than ever
Last Friday, October 22, the sixth edition of IDIBELL’s PhD Day took place in the Faculty of Medicine and Health Sciences of the University of Barcelona. In this edition, it has been presented 10 oral communications and 44 scientific posters.
Nanopolymer treatment prevents the formation of protein aggregates in neurons derived from Parkinson’s patients
One of the hallmarks of Parkinson’s disease is the abnormal accumulation of the α-synuclein protein that causes neuronal death responsible for motor impairments. Dendrimers are highly branched polymers that decrease α-synuclein accumulation in dopaminergic neurons derived from patient stem cells.
Identified two drugs with antitumor activity in preclinical models of malignant pleural cancer
Researchers from IDIBELL and ICO describe that CDK4 and CDK6 inhibitors stop tumor cell proliferation and expand the life expectancy in animal models.
The Viladecans Against Cancer Association launches the new fundraising campaign
Coinciding with the commemoration of World Breast Cancer Day, the Viladecans Against Cancer Association held the opening ceremony of its new fundraising campaign for research
Sónar+D, IDIBELL and L’Hospitalet join forces to do a live experiment that will study the differences when it comes to discovering new music
Curiosity will be the object of study of the scientific experiment “Being a Curious Music-Mind” of IDIBELL with DJ Alicia Carrera, which will take place at the CCCB and Sala Salamandra on October 29 and 30.
miR-424~503, a group of microRNAs that control the development of a type of breast cancer
IDIBELL and UB researchers, together with Mount Sinai, have described a group of microRNAs that would regulate Wnt/β-catenin signalling pathway-dependent breast cancers.
Two new genetic variants associated with suicide attempts help disentangle related risk factors
For the first time, one of the variants identified is unrelated to psychiatric disorders and would contribute through other factors such as smoking, insomnia, or the propensity to risk-taking.
The ability to inhibit mitophagy converts fluorizoline into a promising antitumor agent
Fluorizoline was known for its pro-apoptotic action on various tumor cells. Now, a study by IDIBELL and the University of Barcelona shows that apart from promoting cell death, this compound inhibits the degradation of mitochondria.
Recognition of Dr. Mònica Povedano and the Functional Unit for Motor Neuron Disease work
Dr. Mònica Povedano, principal investigator at IDIBELL and head of the Functional Unit for Motor Neuron Disease at the Bellvitge University Hospital, has been awarded the 2020 Neuromuscular Disease Prize (scientific modality), granted by the Spanish Society of Neurology (SEN).